Fig. 3From: Mass spectrometry quantifies target engagement for a KRASG12C inhibitor in FFPE tumor tissueTarget engagement (TE) of 100 mg per kg of AZD4625 in xenograft models (MIA PaCa-2 or NCI-H2122) is shown as the percent reduction in the median RASG12C protein compared to the time-matched vehicle controlBack to article page